Matt, you had a go at me so this is me responding in kind. Can you make a case commercially to do what you say should be done?
I have case studies from inferior competitors as to the timing needed and costs involved, as a comparison. Please make your case, I'm always wanting to learn but your approach is very one eyed IMO, I'd like to know how you propose TIS do these trials with any commercial benefit?
Please make yourself aware of the current care Chronic Wound Patients go through, then look at what 8 - 12 weeks treatment with VitrGro would give them as a quality of life, it blows any doubt out of the water IMO.
- Forums
- ASX - By Stock
- TIS
- people suffering because of staff availibility
people suffering because of staff availibility, page-22
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)